Hyaluronidase for cervical ripening and induction of labour
- PMID: 16625569
- PMCID: PMC8691265
- DOI: 10.1002/14651858.CD003097.pub2
Hyaluronidase for cervical ripening and induction of labour
Abstract
Background: Dilatation and effacement of the cervix are not only a result of uterine contractions, but are also dependent upon ripening processes within the cervix. The cervix is a fibrous organ composed principally of hyaluronic acid, collagen and proteoglycan. Hyaluronic acid increases markedly after the onset of labour. An increase in the level of hyaluronic acid is associated with an increase in tissue water content. Cervical ripening during labour is characterised by changes of the cervix and an increased water content. Cervical injection of hyaluronidase was postulated to increase cervical ripening. This is one of a series of reviews of methods of cervical ripening and labour induction using standardised methodology.
Objectives: To determine the effects of hyaluronidase for third trimester cervical ripening or induction of labour in comparison with other methods of induction of labour.
Search strategy: We searched the Cochrane Pregnancy and Childbirth Group Trials Register (January 2006) and bibliographies of relevant papers.
Selection criteria: Clinical trials of hyaluronidase for third trimester cervical ripening or labour induction.
Data collection and analysis: A strategy was developed to deal with the large volume and complexity of trial data relating to labour induction. This involved a two-stage method of data extraction. We assessed trial quality. We contacted study authors for additional information. We collected adverse effects information from the trials.
Main results: One trial, with 168 women participating, was included in the review. When compared with placebo for cervical ripening intracervical injections of hyaluronidase resulted in women receiving significantly fewer caesarean sections (18% versus 49%, relative risk (RR) 0.37, 95% confidence interval (CI) 0.22 to 0.61), less need for oxytocin augmentation (10% versus 47%, RR 0.20, 95% CI 0.10 to 0.41), and increased cervical favourability after 24 hours (60% versus 98%, RR 0.62, 95% CI 0.52 to 0.74). No side-effects for mother or baby were reported in this trial.
Authors' conclusions: Intracervical injections of hyaluronidase for cervical ripening appear beneficial. However, this is not common practice. In addition it is an invasive procedure that women may find unacceptable in the presence of less invasive methods.
Conflict of interest statement
None known.
Figures
Update of
-
Hyaluronidase for cervical priming and induction of labour.Cochrane Database Syst Rev. 2001;(2):CD003097. doi: 10.1002/14651858.CD003097. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003097. doi: 10.1002/14651858.CD003097.pub2. PMID: 11406074 Updated.
References
References to studies included in this review
Spallicci 2003 {published and unpublished data}
-
- Spallicci MDB, Bittar RE. Randomized double blind study of ripening the cervix with hyaluronidase in term gestations [Estudo clinico aleatorizado com grupo controle e mascaramento duplo da maturacao do colo uterino pela hialuronidase em gestacoes a termo]. Revista Brasileira de Ginecologia e Obstetricia 2003;25:67.
-
- Spallicci MDB, Chiea M, Bittar R, Singer Motta J, Basto De Alberquerque P, Zugaib M. Hyaluronidase: a new approach to cervical ripening in pregnancies at term. Personal Communication 2002.
References to studies excluded from this review
Penev 1982 {published data only}
-
- Penev I. Artificial dilatation of the cervix uteri with dexamethasone and hyaluronidase: application during labor in women with prolonged pregnancy [Izkustveno uzriavane na matochnata shiika chrez dekametazon i khialuronidaza: Prilozhenie pri razhdaniia s prenosena bremenost]. Akusherstvo i Ginekologiia 1982;21(6):433‐99. - PubMed
Additional references
Alfirevic 2006
Boulvain 2001
Boulvain 2005
Boulvain 2008
Bricker 2000
Clarke 2000
-
- Clarke M, Oxman AD, editors. Cochrane Reviewers’ Handbook 4.1 [updated June 2000]. In: Review Manager (RevMan) [Computer program]. Version 4.1. Oxford, England: The Cochrane Collaboration, 2000.
Curtis 1987
-
- Curtis P, Evans S, Resnick J. Uterine hyperstimulation. The need for standard terminology. Journal of Reproductive Medicine 1987;32:91‐5. - PubMed
French 2001
Green 1967
-
- Green PS. Intracervical injection of hyaluronidase. Effect on dilatation and length of labor. American Journal of Obstetrics and Gynecology 1967;99:337‐40. - PubMed
Hapangama 2009
Hofmeyr 2000
Hofmeyr 2003
Howarth 2001
Hutton 2001
Kavanagh 2001b
Kavanagh 2005
Kavanagh 2006
Kelly 2001a
Kelly 2001b
Kelly 2001c
Kelly 2003
Kelly 2008
Kobayashi 1999
-
- Kobayashi H, Sun GW, Tanaka Y, Kondo T, Terao T. Serum hyaluronic acid levels during pregnancy and labor. Obstetrics & Gynecology 1999;93:480‐4. - PubMed
Li 1994
-
- Li WJ, Li ZL, Ha KW. Effect of hyaluronidase on cervical ripening. Chinese Medical Journal 1994;107:552‐3. - PubMed
Luckas 2000
Muzonzini 2004
Ogawa 1998
-
- Ogawa M, Hirano H, Tsubaki H, Kodama H, Tanaka T. The role of cytokines in cervical ripening: correlations between the concentrations of cytokines and hyaluronic acid in cervical mucus and the induction of hyaluronic acid production by inflammatory cytokines by human cervical fibroblasts. American Journal of Obstetrics and Gynecology 1998;179:105‐10. - PubMed
Smith 2003
Smith 2004
References to other published versions of this review
Kavanagh 2001a
-
- Kavanagh J, Kelly AJ, Thomas J. Hyaluronidase for cervical priming and induction of labour. Cochrane Database of Systematic Reviews 2001, Issue 2. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
